| Product Unit Size | Cost | Quantity | Stock |
|---|
Atenolol is an antagonist at β1-adrenergic receptors that is clinically acceptable for the treatment of hypertension, angina, myocardial infarction, and tachycardia. Atenolol exhibits antihypertensive and anti-anginal activities, primarily through decreasing cardiac output.
| Cas No. | 29122-68-7 |
|---|---|
| Purity | ≥98% |
| Formula | C14H22N2O3 |
| Formula Wt. | 266.34 |
| Chemical Name | 4-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzeneacetamide |
| IUPAC Name | 2-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]acetamide |
| Synonym | Atehexal, Atenol, Cuxanorm, Ibinolo, Myocord, Prenormine, Tenoblock, Uniloc |
| Melting Point | 150-152°C |
| Solubility | Soluble in acetic acid and DMSO. Slightly soluble in water and isopropanol. Practically insoluble in acetonitrile, ethylacetate and chloroform. |
| Appearance | White or Almost White Crystalline Powder |
| Store Temp | Ambient |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Cockcroft JR, Pedersen ME. β-blockade: benefits beyond blood pressure reduction? J Clin Hypertens (Greenwich). 2012 Feb;14(2):112-20. PMID: 22277144.
Thadani U. Beta blockers in hypertension. Am J Cardiol. 1983 Nov 10;52(9):10D-15D. PMID: 6139008.
